MYX 3.29% $4.40 mayne pharma group limited

Ann: Mayne Pharma to restate US dermatology net revenue for FY22, page-3

  1. 1,452 Posts.
    lightbulb Created with Sketch. 29
    Ha ha ha . This company never gets it right . Just seems to be ongoing issues and constant surprises. If they report some amazing results in the future would you actually believe them . I’m one long suffering shareholder . Bought in before there generics takeover and participated to the max in the resulting spp and have watched what can only be called a circus ever since.


 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.